EMPA-REG OUTCOME®

The EMPA-REG OUTCOME® trial assessed the CV safety of empagliflozin versus placebo

EMPA-REG OUTCOME®
Rate this content
  • EMPA-REG OUTCOME®
  • EMPA-REG OUTCOME®
  • EMPA-REG OUTCOME®
  • EMPA-REG OUTCOME®: a randomised, double-blind, placebo-controlled CV outcomes trial
  • EMPA-REG OUTCOME® trial design
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go